EMERYVILLE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

Foldable OLED large panels present challenges such as high background capacitance, extreme display noise, and limited sensing time,” said Sam Toba, Director of Product Marketing at Synaptics. “These ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

EMERYVILLE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

AMD  announced the new Google Cloud C4D and H4D virtual machines (VMs) are powered by 5th Gen AMD EPYCtm processors. The latest additions to Google Cloud's general-purpose and HPC-optimized VMs ...

2-Year U.S. Treasury Note Continuous Contract $103.922 0.129 0.12% 5-Year U.S. Treasury Note Continuous Contract $108.531 0.117 0.11% 10-Year U.S. Treasury Note Continuous Contract $111.094-0.078 ...

Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented Initiation of Phase ...

ParaZero (PRZO) Technologies announced it has received a written notice from the Nasdaq Stock Market LLC indicating that the company is not in compliance with the minimum bid price requirement for ...

We recently published a list of 13 Best NASDAQ Stocks to Buy So Far in 2025. In this article, we are going to take a look at where Marvell Technology Inc. (NASDAQ:MRVL) stands against other NASDAQ ...

However, as Dan Ives maintains a bullish long-term potential on tech for companies with strong fundamentals, we’re here with a list of the 13 best NASDAQ stocks to buy so far in 2025.

The Nasdaq Composite (NASDAQINDEX: ^IXIC) is officially in a bear market. While it had been floating around in correction territory for a few weeks, it fell more than 20% below its all-time high ...

XORTX Therapeutics (XRTX) announces receipt of notification from the Nasdaq Stock Market LLC Listing Qualifications Department that it is not in compliance with the minimum bid price requirement ...